SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-038455
Filing Date
2024-03-29
Accepted
2024-03-29 10:36:09
Documents
2
Period of Report
2024-03-21

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 12553
2 EX-24 svra-ex24.htm EX-24 16183
  Complete submission text file 0000950170-24-038455.txt   30482
Mailing Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746
Business Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746 51285113796
Savara Inc (Issuer) CIK: 0001160308 (see all company filings)

IRS No.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1717 LANGHORNE NEWTOWN RD. SUITE 300 LANGHORNE PA 19047
Business Address
Erickson Anne (Reporting) CIK: 0002016865 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-32157 | Film No.: 24802485